Trial by Algorithm: Who Gets Picked for Life-Saving Drugs?
The call to join a clinical trial once arrived by letter or through a physician’s referral. Today, it is increasingly mediated by algorithms—software that sifts through millions of patient records to identify who qualifies for a potentially life-saving experimental therapy. The promise is speed and efficiency: instead of months of recruitment, a trial might fill in weeks. But hidden within that speed are profound ethical questions. Who gets chosen, who is excluded, and who decides what “fit” really means when the gatekeeper is not a human but a machine?
Trial by Algorithm: Who Gets Picked for Life-Saving Drugs? Read More »










